Condition (MeSH)
Fibromuscular Dysplasia
ClinicalTrials.gov lists 17 trials for Fibromuscular Dysplasia or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
17 of the 17 trials are tagged with Fibromuscular Dysplasia itself; the rest are tagged with a narrower condition beneath it.
When did Fibromuscular Dysplasia trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 3
- Not applicable
- Observational
Top of scale: 3
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 2 |
| 2022 | 1 |
| 2021 | 1 |
| 2019 | 3 |
| 2018 | 2 |
| 2016 | 1 |
| 2013 | 3 |
| 2011 | 1 |
| 2009 | 3 |
No forecast is made for this condition: it averages 0.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 2 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Fibromuscular Dysplasia trials in? (4)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 3 | 1 |
| Not applicable | 6 |
| Observational | 9 |
How many Fibromuscular Dysplasia trials are recruiting? (5)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 7 |
| Active, not recruiting | 1 |
| Completed | 6 |
| Withdrawn | 1 |
| Unknown status | 2 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Interventions as named in the registry (5)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| BLOOD SAMPLES | 1 |
| Contrast Enhanced Ultrasound (CEUS) | 1 |
| Urine sampling | 1 |
| BLOOD SAMPLE | 1 |
| Blood Sampling | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Fibromuscular Dysplasia? (33)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Current Therapy for Carotid Webs. | Annals of vascular surgery | 2025 | Yes |
| Carotid webs: a review of pathophysiology, diagnostic findings, and treatment options. | Journal of neurointerventional surgery | 2024 | Yes |
| Insights from intravascular pressure measurement of renal artery revascularization in patients with fibromuscular dysplasia: The DYSART study. | Journal of vascular surgery | 2022 | Yes |
| Characteristics and Prognosis of Patients With Fibromuscular Dysplasia in a Population of Spontaneous Coronary Artery Dissections (from the French Registry of Spontaneous Coronary Artery Dissections "DISCO"). | The American journal of cardiology | 2022 | Yes |
| Graft Arterial Dissection and Thrombosis After Kidney Transplantation With Undiagnosed Fibromuscular Dysplasia From a Deceased Donor: Case Report and Review. | Transplantation proceedings | 2022 | Yes |
Showing 5 of 33 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and rare-disease identity.